Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia

The government of Indonesia has established a commitment to the provision of affordable medicines. The retail price of unbranded generic cannot exceed the maximum retail price set by the Ministry of Health. The generic medicine pricing policy that has been implemented by the Indonesian government mu...

Full description

Saved in:

Bibliographic Details
Main Author:	Anggriani, Yusi
Format:	Thesis
Language:	English
Published:	2013
Subjects:	RS1-441 Pharmacy and materia medica
Online Access:	http://eprints.usm.my/46472/1/Yusi%20Anggriani24.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-usm-ep.46472
record_format	uketd_dc
spelling	my-usm-ep.464722020-03-09T03:23:03Z Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia 2013-02 Anggriani, Yusi RS1-441 Pharmacy and materia medica The government of Indonesia has established a commitment to the provision of affordable medicines. The retail price of unbranded generic cannot exceed the maximum retail price set by the Ministry of Health. The generic medicine pricing policy that has been implemented by the Indonesian government must be evaluated. The objectives of this study were to evaluate the impact on the price, availability and affordability of selected medicines and to evaluate the context, process, evidence and links of generic medicine pricing policies development in Indonesia. The first part of the study was conducted using a standardized methodology developed by the World Health Organization and Health Action International. The prices, availability and affordability of 50 medicines were measured at public, private and NGO facilities in four provinces in Indonesia (Sumatera Selatan, Jakarta, Yogyakarta and Sulawesi Selatan). The type of medicines selected were Lowest Price Generics (LPGs) and Innovator Brands (IBs). The 2009 International Reference Price (IRP) was used to calculate the median price ratio (MPR). The second part of the study was conducted using the following methods: a review of medicine pricing policies documents, in-depth interviews with 10 key informants and 10 observations of meetings about medicine prices. Transcripts were generated and analyzed using qualitative content analysis. Triangulation was applied to the comparative information obtained from document reviews, in-depth interviews, and meeting observations. The results showed that the public sector procurement price was still inefficient (MPRs=1.36). Public sector procurement price is efficient if the MPR ≤ 1. 2013-02 Thesis http://eprints.usm.my/46472/ http://eprints.usm.my/46472/1/Yusi%20Anggriani24.pdf application/pdf en public phd doctoral Universiti Sains Malaysia Pusat Pengajian Sains Farmasi
institution	Universiti Sains Malaysia
collection	USM Institutional Repository
language	English
topic	RS1-441 Pharmacy and materia medica
spellingShingle	RS1-441 Pharmacy and materia medica Anggriani, Yusi Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
description	The government of Indonesia has established a commitment to the provision of affordable medicines. The retail price of unbranded generic cannot exceed the maximum retail price set by the Ministry of Health. The generic medicine pricing policy that has been implemented by the Indonesian government must be evaluated. The objectives of this study were to evaluate the impact on the price, availability and affordability of selected medicines and to evaluate the context, process, evidence and links of generic medicine pricing policies development in Indonesia. The first part of the study was conducted using a standardized methodology developed by the World Health Organization and Health Action International. The prices, availability and affordability of 50 medicines were measured at public, private and NGO facilities in four provinces in Indonesia (Sumatera Selatan, Jakarta, Yogyakarta and Sulawesi Selatan). The type of medicines selected were Lowest Price Generics (LPGs) and Innovator Brands (IBs). The 2009 International Reference Price (IRP) was used to calculate the median price ratio (MPR). The second part of the study was conducted using the following methods: a review of medicine pricing policies documents, in-depth interviews with 10 key informants and 10 observations of meetings about medicine prices. Transcripts were generated and analyzed using qualitative content analysis. Triangulation was applied to the comparative information obtained from document reviews, in-depth interviews, and meeting observations. The results showed that the public sector procurement price was still inefficient (MPRs=1.36). Public sector procurement price is efficient if the MPR ≤ 1.
format	Thesis
qualification_name	Doctor of Philosophy (PhD.)
qualification_level	Doctorate
author	Anggriani, Yusi
author_facet	Anggriani, Yusi
author_sort	Anggriani, Yusi
title	Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_short	Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_full	Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_fullStr	Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_full_unstemmed	Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia
title_sort	medicine pricing policies: the impact on availability and affordability in four provinces in indonesia
granting_institution	Universiti Sains Malaysia
granting_department	Pusat Pengajian Sains Farmasi
publishDate	2013
url	http://eprints.usm.my/46472/1/Yusi%20Anggriani24.pdf
_version_	1747821678846541824

Medicine Pricing Policies: The Impact On Availability And Affordability In Four Provinces In Indonesia

Similar Items